Skip to Main Content

Paper Details

Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism.
J Nephrol
20
2017
Author NameAffiliation
Thorsten FeldkampUniversity Hospital Schleswig-Holstein, Christian-Albrechts University Kiel
  • 1 - 1

Datasets

Release 1.2